1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Ovarian Cancer - Pipeline Review, 2015

Ovarian Cancer - Pipeline Review, 2015

  • October 2015
  • -
  • Global Data
  • -
  • 174 pages

Ovarian Cancer - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Ovarian Cancer - Pipeline Review, 2015" provides an overview of Ovarian Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ovarian Cancer diagnostic tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ovarian Cancer diagnostic tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ovarian Cancer diagnostic tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Ovarian Cancer - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Ovarian Cancer Overview 15
3 Products under Development 16
3.1 Ovarian Cancer - Pipeline Products by Stage of Development 16
3.2 Ovarian Cancer - Pipeline Products by Territory 17
3.3 Ovarian Cancer - Pipeline Products by Regulatory Path 18
3.4 Ovarian Cancer - Pipeline Products by Estimated Approval Date 19
3.5 Ovarian Cancer - Ongoing Clinical Trials 20
4 Ovarian Cancer - Pipeline Products under Development by Companies 21
4.1 Ovarian Cancer Companies - Pipeline Products by Stage of Development 21
4.2 Ovarian Cancer - Pipeline Products by Stage of Development 25
5 Ovarian Cancer Companies and Product Overview 29
5.1 AandG Pharmaceutical, Inc. Company Overview 29
5.1.1 AandG Pharmaceutical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
5.2 Abcodia Ltd. Company Overview 31
5.2.1 Abcodia Ltd. Pipeline Products and Ongoing Clinical Trials Overview 31
5.3 Abnova Corporation Company Overview 32
5.3.1 Abnova Corporation Pipeline Products and Ongoing Clinical Trials Overview 32
5.4 Adaptive Biotechnologies Corporation Company Overview 34
5.4.1 Adaptive Biotechnologies Corporation Pipeline Products and Ongoing Clinical Trials Overview 34
5.5 Almac Diagnostics Limited Company Overview 35
5.5.1 Almac Diagnostics Limited Pipeline Products and Ongoing Clinical Trials Overview 35
5.6 AroCell AB Company Overview 36
5.6.1 AroCell AB Pipeline Products and Ongoing Clinical Trials Overview 36
5.7 Arrayit Diagnostics, Inc. Company Overview 37
5.7.1 Arrayit Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
5.8 ArtemixRx Company Overview 39
5.8.1 ArtemixRx Pipeline Products and Ongoing Clinical Trials Overview 39
5.9 Aurelium BioPharma Inc. (Inactive) Company Overview 40
5.9.1 Aurelium BioPharma Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 40
5.10 Axela Inc. Company Overview 42
5.10.1 Axela Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.11 Ayanda Biosystems S.A. Company Overview 43
5.11.1 Ayanda Biosystems S.A. Pipeline Products and Ongoing Clinical Trials Overview 43
5.12 Becton, Dickinson and Company Company Overview 44
5.12.1 Becton, Dickinson and Company Pipeline Products and Ongoing Clinical Trials Overview 44
5.13 Bioindustry Park Silvano Fumero S.p.A. Company Overview 46
5.13.1 Bioindustry Park Silvano Fumero S.p.A. Pipeline Products and Ongoing Clinical Trials Overview 46
5.14 BioMark Diagnostics Inc. Company Overview 47
5.14.1 BioMark Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
5.15 Ceres Nanosciences, Inc. Company Overview 48
5.15.1 Ceres Nanosciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
5.16 Chronix Biomedical, Inc. Company Overview 50
5.16.1 Chronix Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
5.17 Clarient, Inc. Company Overview 52
5.17.1 Clarient, Inc. Pipeline Products and Ongoing Clinical Trials Overview 52
5.18 ClavGen Therapeutics LLC Company Overview 53
5.18.1 ClavGen Therapeutics LLC Pipeline Products and Ongoing Clinical Trials Overview 53
5.19 Cleveland Diagnostics Inc. Company Overview 54
5.19.1 Cleveland Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
5.20 Clovis Oncology, Inc. Company Overview 55
5.20.1 Clovis Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
5.21 Cornell University Company Overview 57
5.21.1 Cornell University Pipeline Products and Ongoing Clinical Trials Overview 57
5.22 Courtagen Life Sciences, Inc. Company Overview 58
5.22.1 Courtagen Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 58
5.23 CS-Keys, Inc. Company Overview 59
5.23.1 CS-Keys, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
5.24 Dako A/S Company Overview 60
5.24.1 Dako A/S Pipeline Products and Ongoing Clinical Trials Overview 60
5.25 Dana-Farber Cancer Institute, Inc. Company Overview 61
5.25.1 Dana-Farber Cancer Institute, Inc. Pipeline Products and Ongoing Clinical Trials Overview 61
5.26 diaDexus, Inc. Company Overview 62
5.26.1 diaDexus, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
5.27 Eventus Diagnostics, Inc. Company Overview 67
5.27.1 Eventus Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 67
5.28 Exiqon A/S Company Overview 68
5.28.1 Exiqon A/S Pipeline Products and Ongoing Clinical Trials Overview 68
5.29 Exosomics Siena SpA Company Overview 70
5.29.1 Exosomics Siena SpA Pipeline Products and Ongoing Clinical Trials Overview 70
5.30 Foundation Medicine, Inc. Company Overview 71
5.30.1 Foundation Medicine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
5.31 Ganymed Pharmaceuticals AG Company Overview 73
5.31.1 Ganymed Pharmaceuticals AG Pipeline Products and Ongoing Clinical Trials Overview 73
5.32 GeneNews Limited Company Overview 74
5.32.1 GeneNews Limited Pipeline Products and Ongoing Clinical Trials Overview 74
5.33 Georgia Institute of Technology Company Overview 76
5.33.1 Georgia Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 76
5.34 GlycoZym Company Overview 78
5.34.1 GlycoZym Pipeline Products and Ongoing Clinical Trials Overview 78
5.35 H. Lee Moffitt Cancer Center and Research Institute, Inc. Company Overview 79
5.35.1 H. Lee Moffitt Cancer Center and Research Institute, Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
5.36 Ikonisys, Inc. Company Overview 80
5.36.1 Ikonisys, Inc. Pipeline Products and Ongoing Clinical Trials Overview 80
5.37 Inanovate (UK) Ltd. Company Overview 81
5.37.1 Inanovate (UK) Ltd. Pipeline Products and Ongoing Clinical Trials Overview 81
5.38 IncellDx, Inc. Company Overview 82
5.38.1 IncellDx, Inc. Pipeline Products and Ongoing Clinical Trials Overview 82
5.39 Innovative Health Diagnostics Company Overview 83
5.39.1 Innovative Health Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 83
5.40 Institut National de la Sante et de la Recherche Medicale Company Overview 84
5.40.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products and Ongoing Clinical Trials Overview 84
5.41 InterGenetics Incorporated Company Overview 85
5.41.1 InterGenetics Incorporated Pipeline Products and Ongoing Clinical Trials Overview 85
5.42 IV Diagnostics, Inc. Company Overview 86
5.42.1 IV Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 86
5.43 KIYATEC Inc. Company Overview 87
5.43.1 KIYATEC Inc. Pipeline Products and Ongoing Clinical Trials Overview 87
5.44 Lab Discoveries Ltd. Company Overview 88
5.44.1 Lab Discoveries Ltd. Pipeline Products and Ongoing Clinical Trials Overview 88
5.45 Laboratorios SALVAT S.A. Company Overview 89
5.45.1 Laboratorios SALVAT S.A. Pipeline Products and Ongoing Clinical Trials Overview 89
5.46 Laboratory Corporation of America Holdings Company Overview 90
5.46.1 Laboratory Corporation of America Holdings Pipeline Products and Ongoing Clinical Trials Overview 90
5.47 Louisville Bioscience, Inc. Company Overview 92
5.47.1 Louisville Bioscience, Inc. Pipeline Products and Ongoing Clinical Trials Overview 92
5.48 MabCure Inc. Company Overview 93
5.48.1 MabCure Inc. Pipeline Products and Ongoing Clinical Trials Overview 93
5.49 Manalto Limited Company Overview 95
5.49.1 Manalto Limited Pipeline Products and Ongoing Clinical Trials Overview 95
5.50 MDNA Life Sciences, Inc. Company Overview 100
5.50.1 MDNA Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 100
5.51 MDxHealth SA Company Overview 101
5.51.1 MDxHealth SA Pipeline Products and Ongoing Clinical Trials Overview 101
5.52 Metabolon, Inc. Company Overview 103
5.52.1 Metabolon, Inc. Pipeline Products and Ongoing Clinical Trials Overview 103
5.53 Milagen, Inc. Company Overview 104
5.53.1 Milagen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 104
5.54 Myriad Genetics, Inc. Company Overview 105
5.54.1 Myriad Genetics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 105
5.55 Nanosphere, Inc. Company Overview 107
5.55.1 Nanosphere, Inc. Pipeline Products and Ongoing Clinical Trials Overview 107
5.56 National University of Singapore Company Overview 109
5.56.1 National University of Singapore Pipeline Products and Ongoing Clinical Trials Overview 109
5.57 Neogenix Oncology, Inc. Company Overview 110
5.57.1 Neogenix Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 110
5.58 Novel Bio-spectrum Technologies, Inc. Company Overview 111
5.58.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 111
5.59 NuCana BioMed Limited Company Overview 112
5.59.1 NuCana BioMed Limited Pipeline Products and Ongoing Clinical Trials Overview 112
5.60 Oncgnostics GmbH Company Overview 113
5.60.1 Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 113
5.61 Orion Genomics LLC Company Overview 114
5.61.1 Orion Genomics LLC Pipeline Products and Ongoing Clinical Trials Overview 114
5.62 Oryzon Genomics S.A. Company Overview 115
5.62.1 Oryzon Genomics S.A. Pipeline Products and Ongoing Clinical Trials Overview 115
5.63 OTraces Inc. Company Overview 116
5.63.1 OTraces Inc. Pipeline Products and Ongoing Clinical Trials Overview 116
5.64 OvaGene Oncology Inc. Company Overview 117
5.64.1 OvaGene Oncology Inc. Pipeline Products and Ongoing Clinical Trials Overview 117
5.65 PeriRx LLC Company Overview 118
5.65.1 PeriRx LLC Pipeline Products and Ongoing Clinical Trials Overview 118
5.66 Pronota NV Company Overview 119
5.66.1 Pronota NV Pipeline Products and Ongoing Clinical Trials Overview 119
5.67 Protagen AG Company Overview 120
5.67.1 Protagen AG Pipeline Products and Ongoing Clinical Trials Overview 120
5.68 Proteomika Company Overview 121
5.68.1 Proteomika Pipeline Products and Ongoing Clinical Trials Overview 121
5.69 Provista Diagnostics Inc. Company Overview 122
5.69.1 Provista Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 122
5.70 RCP Diagnostics, LLC (Inactive) Company Overview 123
5.70.1 RCP Diagnostics, LLC (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 123
5.71 RiboMed Biotechnologies, Inc. Company Overview 124
5.71.1 RiboMed Biotechnologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 124
5.72 Rice University Company Overview 125
5.72.1 Rice University Pipeline Products and Ongoing Clinical Trials Overview 125
5.73 Roche Diagnostics International Ltd. Company Overview 127
5.73.1 Roche Diagnostics International Ltd. Pipeline Products and Ongoing Clinical Trials Overview 127
5.74 Rosetta Genomics, Ltd. Company Overview 129
5.74.1 Rosetta Genomics, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 129
5.75 Rush University Medical Center Company Overview 131
5.75.1 Rush University Medical Center Pipeline Products and Ongoing Clinical Trials Overview 131
5.76 SomaLogic, Inc. Company Overview 132
5.76.1 SomaLogic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 132
5.77 Soricimed Biopharma Inc. Company Overview 133
5.77.1 Soricimed Biopharma Inc. Pipeline Products and Ongoing Clinical Trials Overview 133
5.78 Stage I Diagnostics, Inc. Company Overview 135
5.78.1 Stage I Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 135
5.79 SurExam Life Science and Technology Co. Company Overview 136
5.79.1 SurExam Life Science and Technology Co. Pipeline Products and Ongoing Clinical Trials Overview 136
5.80 Target Discovery, Inc. Company Overview 137
5.80.1 Target Discovery, Inc. Pipeline Products and Ongoing Clinical Trials Overview 137
5.81 Teva Pharmaceutical Industries Limited Company Overview 138
5.81.1 Teva Pharmaceutical Industries Limited Pipeline Products and Ongoing Clinical Trials Overview 138
5.82 The Johns Hopkins University Company Overview 140
5.82.1 The Johns Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 140
5.83 The University of Adelaide Company Overview 142
5.83.1 The University of Adelaide Pipeline Products and Ongoing Clinical Trials Overview 142
5.84 The University of Texas M. D. Anderson Cancer Center Company Overview 143
5.84.1 The University of Texas M. D. Anderson Cancer Center Pipeline Products and Ongoing Clinical Trials Overview 143
5.85 Todos Medical Company Overview 144
5.85.1 Todos Medical Pipeline Products and Ongoing Clinical Trials Overview 144
5.86 Transbiomed, SL Company Overview 145
5.86.1 Transbiomed, SL Pipeline Products and Ongoing Clinical Trials Overview 145
5.87 Universite de Montreal Company Overview 146
5.87.1 Universite de Montreal Pipeline Products and Ongoing Clinical Trials Overview 146
5.88 University of South Florida Company Overview 148
5.88.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 148
5.89 US Biomarkers, Inc. Company Overview 150
5.89.1 US Biomarkers, Inc. Pipeline Products and Ongoing Clinical Trials Overview 150
5.90 Vermillion, Inc. Company Overview 151
5.90.1 Vermillion, Inc. Pipeline Products and Ongoing Clinical Trials Overview 151
5.91 Vitatex Inc. Company Overview 154
5.91.1 Vitatex Inc. Pipeline Products and Ongoing Clinical Trials Overview 154
5.92 Vitruvian Biomedical, Inc. Company Overview 157
5.92.1 Vitruvian Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 157
5.93 Yale University Company Overview 158
5.93.1 Yale University Pipeline Products and Ongoing Clinical Trials Overview 158
6 Ovarian Cancer- Recent Developments 159
7 Appendix 171
7.1 Methodology 171
7.2 About GlobalData 173
7.3 Contact Us 174
7.4 Disclaimer 174

1.1 List of Tables
Table 1: Ovarian Cancer - Pipeline Products by Stage of Development 16
Table 2: Ovarian Cancer - Pipeline Products by Territory 17
Table 3: Ovarian Cancer - Pipeline Products by Regulatory Path 18
Table 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date 19
Table 5: Ovarian Cancer - Ongoing Clinical Trials 20
Table 6: Ovarian Cancer Companies - Pipeline Products by Stage of Development 21
Table 7: Ovarian Cancer - Pipeline Products by Stage of Development 25
Table 8: AandG Pharmaceutical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
Table 9: Companion Diagnostic Test - Ovarian Cancer - Product Status 30
Table 10: Companion Diagnostic Test - Ovarian Cancer - Product Description 30
Table 11: Abcodia Ltd. Pipeline Products and Ongoing Clinical Trials Overview 31
Table 12: ROCA Diagnostic Test - Product Status 31
Table 13: ROCA Diagnostic Test - Product Description 31
Table 14: Abnova Corporation Pipeline Products and Ongoing Clinical Trials Overview 32
Table 15: Biomarker Test - Ovarian Cancer - Product Status 33
Table 16: Biomarker Test - Ovarian Cancer - Product Description 33
Table 17: Adaptive Biotechnologies Corporation Pipeline Products and Ongoing Clinical Trials Overview 34
Table 18: tilSEQ Assay - Product Status 34
Table 19: tilSEQ Assay - Product Description 34
Table 20: Almac Diagnostics Limited Pipeline Products and Ongoing Clinical Trials Overview 35
Table 21: Diagnostic Test - Ovarian Cancer - Product Status 35
Table 22: Diagnostic Test - Ovarian Cancer - Product Description 35
Table 23: AroCell AB Pipeline Products and Ongoing Clinical Trials Overview 36
Table 24: TK 210 Assay - Ovarian Cancer - Product Status 36
Table 25: TK 210 Assay - Ovarian Cancer - Product Description 36
Table 26: Arrayit Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 27: OvaDx - Product Status 38
Table 28: OvaDx - Product Description 38
Table 29: ArtemixRx Pipeline Products and Ongoing Clinical Trials Overview 39
Table 30: ArtemixRx Prognostic Test - Ovarian Cancer - Product Status 39
Table 31: ArtemixRx Prognostic Test - Ovarian Cancer - Product Description 39
Table 32: Aurelium BioPharma Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 40
Table 33: MMD ELISA Test For Ovarian Cancer - Product Status 40
Table 34: MMD ELISA Test For Ovarian Cancer - Product Description 40
Table 35: Ovarian Cancer Screening Test - Product Status 41
Table 36: Ovarian Cancer Screening Test - Product Description 41
Table 37: Axela Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 38: Multiplex Ovarian Cancer Biomarker Assay - Product Status 42
Table 39: Multiplex Ovarian Cancer Biomarker Assay - Product Description 42
Table 40: Ayanda Biosystems S.A. Pipeline Products and Ongoing Clinical Trials Overview 43
Table 41: Diagnostic Test - Ovarian Cancer - Product Status 43
Table 42: Diagnostic Test - Ovarian Cancer - Product Description 43
Table 43: Becton, Dickinson and Company Pipeline Products and Ongoing Clinical Trials Overview 44
Table 44: Diagnostic Test - Ovarian Cancer - Product Status 45
Table 45: Diagnostic Test - Ovarian Cancer - Product Description 45
Table 46: Bioindustry Park Silvano Fumero S.p.A. Pipeline Products and Ongoing Clinical Trials Overview 46
Table 47: Diagnostic Kit - Ovarian Cancer - Product Status 46
Table 48: Diagnostic Kit - Ovarian Cancer - Product Description 46
Table 49: BioMark Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 50: Biomarker Assay - Ovarian Cancer - Product Status 47
Table 51: Biomarker Assay - Ovarian Cancer - Product Description 47
Table 52: Ceres Nanosciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 53: Nanotrap Ovarian Cancer Biomarker Test - Product Status 49
Table 54: Nanotrap Ovarian Cancer Biomarker Test - Product Description 49
Table 55: Chronix Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
Table 56: Companion Diagnostic Test - Ovarian Cancer - Product Status 51
Table 57: Companion Diagnostic Test - Ovarian Cancer - Product Description 51
Table 58: Clarient, Inc. Pipeline Products and Ongoing Clinical Trials Overview 52
Table 59: Ovatax - Product Status 52
Table 60: Ovatax - Product Description 52
Table 61: ClavGen Therapeutics LLC Pipeline Products and Ongoing Clinical Trials Overview 53
Table 62: Prognostic Assay - Ovarian Cancer - Product Status 53
Table 63: Prognostic Assay - Ovarian Cancer - Product Description 53
Table 64: Cleveland Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 65: Blood-Based Diagnostic Test - Ovarian Cancer - Product Status 54
Table 66: Blood-Based Diagnostic Test - Ovarian Cancer - Product Description 54
Table 67: Clovis Oncology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
Table 68: Rucaparib Companion Diagnostic Test - Product Status 56
Table 69: Rucaparib Companion Diagnostic Test - Product Description 56
Table 70: Cornell University Pipeline Products and Ongoing Clinical Trials Overview 57
Table 71: Non-Invasive Diagnostic Test - Ovarian Cancer - Product Status 57
Table 72: Non-Invasive Diagnostic Test - Ovarian Cancer - Product Description 57
Table 73: Courtagen Life Sciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 58
Table 74: Ovarian Cancer Diagnostic Panel - Product Status 58
Table 75: Ovarian Cancer Diagnostic Panel - Product Description 58
Table 76: CS-Keys, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
Table 77: caPCNA - Ovarian Cancer - Product Status 59
Table 78: caPCNA - Ovarian Cancer - Product Description 59
Table 79: Dako A/S Pipeline Products and Ongoing Clinical Trials Overview 60
Table 80: MK-8109 Companion Diagnostic Test - Product Status 60
Table 81: MK-8109 Companion Diagnostic Test - Product Description 60
Table 82: Dana-Farber Cancer Institute, Inc. Pipeline Products and Ongoing Clinical Trials Overview 61
Table 83: Biomarker Assay - Ovarian Carcinoma - Product Status 61
Table 84: Biomarker Assay - Ovarian Carcinoma - Product Description 61
Table 85: diaDexus, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
Table 86: B7-H4 Assay - Product Status 63
Table 87: B7-H4 Assay - Product Description 63
Table 88: DcR3 (DD-C248) Assay - Product Status 64
Table 89: DcR3 (DD-C248) Assay - Product Description 64
Table 90: MIC-1 (DD-X065) Assay - Product Status 65
Table 91: MIC-1 (DD-X065) Assay - Product Description 65
Table 92: Spondin-2 (DD-P108) Assay - Product Status 66
Table 93: Spondin-2 (DD-P108) Assay - Product Description 66
Table 94: Eventus Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 95: Octava Test - Ovarian Cancer - Product Status 67
Table 96: Octava Test - Ovarian Cancer - Product Description 67
Table 97: Exiqon A/S Pipeline Products and Ongoing Clinical Trials Overview 68
Table 98: miRNA test-Ovarian - Product Status 69
Table 99: miRNA test-Ovarian - Product Description 69
Table 100: Exosomics Siena SpA Pipeline Products and Ongoing Clinical Trials Overview 70
Table 101: EXOTEST Ovarian - Product Status 70
Table 102: EXOTEST Ovarian - Product Description 70
Table 103: Foundation Medicine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
Table 104: Companion Diagnostic Assay - Rucaparib - Product Status 72
Table 105: Companion Diagnostic Assay - Rucaparib - Product Description 72
Table 106: Ganymed Pharmaceuticals AG Pipeline Products and Ongoing Clinical Trials Overview 73
Table 107: IMAB027 Companion Diagnostic Test - Product Status 73
Table 108: IMAB027 Companion Diagnostic Test - Product Description 73
Table 109: GeneNews Limited Pipeline Products and Ongoing Clinical Trials Overview 74
Table 110: Biomarker Diagnostic Test - Ovarian Cancer - Product Status 75
Table 111: Biomarker Diagnostic Test - Ovarian Cancer - Product Description 75
Table 112: Georgia Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 76
Table 113: Mass Spectrometry Based Ovarian Cancer Test - Product Status 77
Table 114: Mass Spectrometry Based Ovarian Cancer Test - Product Description 77
Table 115: GlycoZym Pipeline Products and Ongoing Clinical Trials Overview 78
Table 116: Diagnostic Assay - Ovarian Cancer - Product Status 78
Table 117: Diagnostic Assay - Ovarian Cancer - Product Description 78
Table 118: H. Lee Moffitt Cancer Center and Research Institute, Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
Table 119: Diagnostic Assay - Ovarian Cancer - Product Status 79
Table 120: Diagnostic Assay - Ovarian Cancer - Product Description 79
Table 121: Ikonisys, Inc. Pipeline Products and Ongoing Clinical Trials Overview 80
Table 122: oncoFISH ovarian - Product Status 80
Table 123: oncoFISH ovarian - Product Description 80
Table 124: Inanovate (UK) Ltd. Pipeline Products and Ongoing Clinical Trials Overview 81
Table 125: Diagnostic Test - Ovarian Cancer - Product Status 81
Table 126: Diagnostic Test - Ovarian Cancer - Product Description 81
Table 127: IncellDx, Inc. Pipeline Products and Ongoing Clinical Trials Overview 82

1.2 List of Figures
Figure 1: Ovarian Cancer - Pipeline Products by Stage of Development 16
Figure 2: Ovarian Cancer - Pipeline Products by Territory 17
Figure 3: Ovarian Cancer - Pipeline Products by Regulatory Path 18
Figure 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date 19
Figure 5: Ovarian Cancer - Ongoing Clinical Trials 20

Companies Mentioned
AandG Pharmaceutical, Inc.
Abcodia Ltd.
Abnova Corporation
Adaptive Biotechnologies Corporation
Almac Diagnostics Limited
AroCell AB
Arrayit Diagnostics, Inc.
ArtemixRx
Axela Inc.
Ayanda Biosystems S.A.
Becton, Dickinson and Company
Bioindustry Park Silvano

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Ovarian Cancer: Analytical Tool

Ovarian Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by Global Data

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the US

  • November 2016
    8 pages
  • Cancer  

  • United States  

View report >

Cancer Statistics in the UK

  • November 2016
    20 pages
  • Cancer  

    Blood Transfusi...  

  • United Kingdom  

    United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.